The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.

A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.

The US FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients.

Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...

According to his LinkedIn, Todd has degrees from Yale University, the University of Massachusetts Medical School, and Havard University. The investigation into Todd is ongoing. Prosecutors urge anyone ...

The FDA says that food companies will have until Jan. 15, 2027 to stop using the dye. Drugmakers will have an extra year, until January 2028, to comply with the change. Red 3, also known as ...

Massachusetts Gov. Maura Healey is hardening her approach to the state’s migrant crisis in the face of mounting safety concerns and just days before President-elect Trump is sworn into office ...

Jan. 14 (UPI) --The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, the FDA announced. "Food should be a vehicle for ...